Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04056026 · ClinicalTrials.gov registry record · Early Phase 1
A Single Dose FMT Infusion as an Adjunct to Keytruda for Metastatic Mesothelioma
A Early Phase 1 study, sponsored by ProgenaBiome.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 1
- Enrollment target
NCT04056026 is a Early Phase 1 study that has completed, run by ProgenaBiome. The registered enrollment target is 1 participants.
The verdict
NCT04056026, a Early Phase 1 study, has completed, sponsored by ProgenaBiome.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 1 participants
- Enrollment target
Study Summary
The investigators propose to ensure a favorable gut microbiome by fecal microbiota transplant to enhance the efficacy Keytruda
Interventions
- BIOLOGICAL Fecal Microbiota Transplant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2018-09-18 |
| Est. Completion | 2018-12-18 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04056026
The ClinicalTrials.gov registry entry for NCT04056026 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ProgenaBiome, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fecal Microbiota Transplant is the first listed.
NCT04056026 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04056026 about?
NCT04056026 is a clinical study titled "A Single Dose FMT Infusion as an Adjunct to Keytruda for Metastatic Mesothelioma". The investigators propose to ensure a favorable gut microbiome by fecal microbiota transplant to enhance the efficacy Keytruda
What is the current status of trial NCT04056026?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 1 participants. The study started on 2018-09-18. Estimated completion is 2018-12-18.
What interventions are being tested in trial NCT04056026?
The interventions under investigation include: Fecal Microbiota Transplant (BIOLOGICAL).
Who is sponsoring clinical trial NCT04056026?
This trial is sponsored by ProgenaBiome, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.